Headspace Health has revealed two acquisitions this year, the latest coming earlier this month when the digital mental health company announced the purchase of mental wellness app Shine.
In a crowded field of mental health startups, the company is using acquisitions to augment its product and add new capabilities. Leslie Witt, Headspace's chief product and design officer, said the Shine deal is...
Decentralized clinical trial company Curebase is partnering with Meru Health on a three-year clinical trial to study the effectiveness of Meru's 12-week treatment program aimed at reducing depression among primary care patients.
Meru Health's smartphone-based, therapist-guided treatment program targets depression, burnout and anxiety, while Curebase provides a decentralized clinical trial...
Both digital and face-to-face cognitive behavioral therapy (CBT) "may be suitable interventions for patients with more severe forms of depression," according to a review published in npj Digital Medicine.
"Overall, our results indicate that after controlling for a number of potential confounders, face-to-face and digital CBT might be comparable in terms of clinical effectiveness for treating...
Akili Interactive hit the public markets in August, bringing in cash the company will use to launch its video game digital therapeutic for children with ADHD later this year.
Akili's product, dubbed EndeavorRx, is prescription software for kids ages 8 to 12 who have attention issues. It received FDA De Novo clearance in 2020 after years waiting for the agency green light, though a nonprescription...
Digital mental health company Headspace Health announced Thursday it has acquired the Shine app, a mental wellness platform focused on culturally competent and inclusive offerings.
Founded in 2016, Shine provides self-guided content, including meditations and self-care courses on topics like stress and boundaries, as well as virtual community workshops.
The company's cofounders and co-CEOs Marah...
Korean researchers develop biosensor to measure serotonin levels in real-time
A research team from the Korea Research Institute of Bioscience and Biotechnology has developed a biosensor that can track serotonin levels in real time for the diagnosis of depression.
Depression, which affects over a million South Koreans, is believed to be partly caused by imbalances in the level of neurotransmitters...
Connected pillbox maker MedMinder received $35 million through a credit facility with SWK Holdings Corporation and additional investment from Accelmed Partners.
The company offers a connected medication dispenser with an interactive screen that alerts polypharmacy patients, seniors and caregivers when it's time to take medications or when a dose is missed. It also provides a service where...
Alma, which makes software and support tools for mental health professionals building their practices, raised $130 million in Series D funding. The round comes about a year after the company announced its $50 million Series C.
The round was led by Thoma Bravo, with participation from Cigna Ventures, Insight Partners, Optum Ventures, Tusk Venture Partners, Primary Venture Partners and Sound...
Woebot Health, maker of a mental health chatbot, recently appointed Dr. Robbert Zusterzeel as vice president of regulatory science and strategy.
Zusterzeel comes to Woebot from IQVIA, where he served as senior director of U.S. regulatory science and strategy. He'd previously worked at the FDA for nearly 10 years.
"We believe in and have embraced regulation from the start and have expanded our...
Akili, maker of a video game-like digital therapeutic for children with ADHD, hit the public markets Monday after wrapping up a merger with special-purpose acquisition company Social Capital Suvretta Holdings Corp. I.
The newly public digital health firm said the deal brought in more than $163 million before paying transaction expenses and advisory fees. Akili plans to use the cash to launch...